National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$35.00
add to cart

Rights & Permissions

topleft topright

Scientific and Medical Aspects of Human Reproductive Cloning (2002)
Committee on Science, Engineering, and Public Policy (COSEPUP)
Board on Life Sciences (BLS)

Citation Manager

. "Appendix C: Workshop Agenda and Speaker Biographical Information." Scientific and Medical Aspects of Human Reproductive Cloning. Washington, DC: The National Academies Press, 2002.

Please select a format:

BibTeX EndNote RefMan


Page
153
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Scientific and Medical of Aspects: Human Reproductive Cloning

response to the midcycle surge of luteinizing hormone thus introducing a delay that seems to make blastocyst formation more likely). He also made clones of a clone in mice.

Panayiotis Michael Zavos is a professor emeritus of reproductive physiology-andrology at the University of Kentucky; founder, director, and chief andrologist of the Andrology Institute of America; cofounder and codirector of the Kentucky Center for Reproductive Medicine and IVF; and president and CEO of ZDL, Inc., a private corporation that markets infertility products and technologies worldwide. He received a BS in biology and chemistry in 1970, an MS in biology and physiology in 1972, and an EdS in 1976 from Emporia State University, in Kansas. Dr. Zavos received his PhD in reproductive physiology and statistics in 1978 from the University of Minnesota in Twin Cities.

Page
153